Skip to main content

Introduction/Definition

  • Chapter
  • First Online:
  • 1035 Accesses

Abstract

The historical development of the isolator technology is shown in [1] and [3]. Isolators are now a part of the pharmaceutical industry [6], which cannot be imagined without. Since its beginnings in the nuclear industry, many isolator applications are new to the chemical and pharmaceutical industries and are used to separate the user, product, and environment consistently from each other. For the pharmaceutical industry of the twenty-first century, containment systems for aseptic processes and the handling of API's have become more important. A modern isolator as it is used in the pharmaceutical industry of today can be designed for the product and process protection and/or for the protection of operators and the environment. Additional safety features and operating costs savings versus conventional clean room approaches are driving the change to containment solutions. Containments can be glove boxes, isolators, or restricted access barrier systems (RABS) . Isolators have captured a firm position in the pharmaceutical industry during the past few years.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Sirch, E.: Isolatortechnik in der pharmazeutischen Industrie: Reinraumtechnik, 2 Aufl. edn. Springer, Berlin (2004)

    Google Scholar 

  2. Ruffieux, P.: 1978–2008, 40 years SKAN AG, 30 Years Isolator Technology. Swiss Pharm. 31(6), Verlag Dr. Felix Wüst AG (2009)

    Google Scholar 

  3. Gail, L., Gommel, U., Hortig, H.-P., (Hersg.): Reinraumtechnik Chap. 7, P. 221. Springer, Berlin (2012)

    Google Scholar 

  4. Pharmaceutical GMP’s for the twenty first Century—A Risk Based Approach; Final Report; Sept 2004; Department of Health and Human Services: U.S. Food and Drug Administration (2004)

    Google Scholar 

  5. VDI 2083, Blatt 16: Reinraumtechnik, Barrieresysteme (Isolatoren, Mini-Environements, Reinraummodule) Wirksamkeit, Zertifizierung, Verein Deutscher Ingenieure (VDI) (2010)

    Google Scholar 

  6. Sigwarth, V., Stark, A.: Effect of carrier materials on the resistance of spores of Bacillus stearothermophilus to gaseous hydrogen peroxide. PDA J. Pharm. Sci. Technol. 57(1), 3–11 (2003)

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans-Jürgen Bässler .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bässler, HJ., Lehmann, F. (2013). Introduction/Definition. In: Containment Technology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39292-4_1

Download citation

Publish with us

Policies and ethics